Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human PARK2 Protein (AC1617)
Cat.#: ACPP-1617
Specifications
Despition PARK2 Human Recombinant SIZE 5 µg Purity > 80% (SDS-PAGE) Form Sterile Filtered clear solution. Storage Store at 4°C for 2-4 weeks. Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1200 PAX8 Blocking Peptide (AC1200) 250 µg inquiry ACPP-1181 Synthetic Nanodisc Human CX3CR1 Protein (AC1181) 10 µg inquiry ACPP-1252 Robo3 Blocking Peptide (AC1252) 250 µg inquiry ACPP-1142 Recombinant Human TrkC Protein (Fc Tag) (AC1142) 50 µg inquiry ACPP-1263 MAPK7 Blocking Peptide (AC1263) 250 µg inquiry ACPP-1500 Mouse PEBP1 Protein (AC1500) 5 µg inquiry ACPP-1160 Recombinant Human GPCR GPR20 Protein (Fc Tag) (AC1160) 50 µg inquiry ACPP-1343 GIRK1 Blocking Peptide (AC1343) 250 µg inquiry ACPP-1785 Human NEUROG3 Protein (AC1785) 2 µg inquiry ACPP-1058 Recombinant Human TrkA Protein (Fc Tag) (AC1058) 50 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket